SOPH
SOPHiA GENETICS SA
NASDAQ · Healthcare · Medical - Healthcare Information Services · CH
$8.19
−3.99%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.20
- Revenue estimate
- $24.0M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.21
- Revenue actual
- $23.3M
- Revenue estimate
- $21.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -26.6%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $12
- PT range
- $9.00 – $14
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.21 | -$0.26 | Miss -23.79% | $23.3M |
| May 5, 2026 | -$0.23 | -$0.27 | Miss -16.13% | $21.7M |
| Mar 3, 2026 | -$0.24 | -$0.28 | Miss -16.67% | $21.7M |
| Nov 4, 2025 | -$0.20 | -$0.30 | Miss -50.00% | $19.5M |
| Mar 4, 2025 | -$0.23 | -$0.23 | In line | $17.7M |
| Mar 5, 2024 | -$0.25 | -$0.37 | Miss -48.00% | $17.0M |
| Mar 7, 2023 | -$0.34 | -$0.22 | Beat 35.29% | $13.4M |
| Mar 15, 2022 | -$0.34 | -$0.33 | Beat 2.94% | $10.9M |
| Nov 10, 2021 | -$0.38 | -$0.35 | Beat 7.89% | $10.4M |
| Sep 9, 2021 | -$0.39 | -$0.31 | Beat 20.51% | $10.2M |
| Dec 31, 2020 | — | -$0.22 | — | $7.8M |
| Sep 30, 2020 | — | -$0.22 | — | $7.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026